Gapping up
News:
- ESPR +23.4% (announces monetization of European royalties and concurrent payoff and termination of existing revenue interest facility)
- INFN +19% (NOK to acquire INFN)
- PTGX +10.3% (to join S&P SmallCap 600)
- CANF +6.6% (reports results from Osteoarthritis Clinical Study in Dogs reported by Can-Fite's Partner Vetbiolix)
- SPRY +6.1% (announces EURneffy (adrenaline nasal spray) recommended for approval by CHMP for emergency treatment of allergic reactions)
- LWAY +5.9% (to dismiss its claims against PCO)
- TIGO +4.7% (Independent committee of Millicom board believes anticipated takeover offer by Atlas at a price of $24/share would significantly undervalue Millicom in light of expected financial performance)
- ELYM +4.6% (closes its acquisition with Tenet Medicines; announces related $120 mln private placement)
- EBR +3.7% (signed a Memorandum of Understanding with Suzano (SUZ) for the development of sustainable solutions based on the use of biogenic CO2 generated in Suzano units)
- PLUG +3.3% (to receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen Facility)
- MRNA +1.5% (Carisma Therapeutics (CARM) announces nomination of first in Vivo CAR-M development candidate for hepatocellular carcinoma under collaboration with MRNA)
- SMCI +1.5% (Barron's out positive on SMCI)
- COIN +1.2% (COIN partners with Stripe to expand global adoption of crypto)
- IMMP +1.1% (reports positive topline results from TACTI-003 Phase IIb Trial in first line head and neck cancer)
- TNYA +1% (announces research leadership updates)